Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy

Addiction

Volumn 98, Issue 1, 2003, Pages 103-110

  Schindler, Shird Dieter ^a   Eder, Harald ^a   Ortner, Romana ^a   Rohrmeister, Klaudia ^a   Langer, Martin ^a   Fischer, Gabriele ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Buprenorphine; Conception; Maintenance; Neonatal abstinence syndrome; Opioid dependence; Pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

APGAR SCORE; ARTICLE; BIRTH; BIRTH WEIGHT; CLINICAL TRIAL; COHORT ANALYSIS; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NEWBORN; OPIATE ADDICTION; PH; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SYMPTOM; URINALYSIS; WITHDRAWAL SYNDROME;

ADULT; BUPRENORPHINE; FEMALE; HUMANS; INFANT, NEWBORN; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037220477     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2003.00245.x     Document Type: Article

References (36)

1. American Psychiatric Association (APA) (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th Edn. Washington, DC: APA.
2. Blinick, G., Jerez, E. & Wallach, R. C. (1973) Methadone maintenance, pregnancy and progeny. Journal of the American Medical Association. 225, 477-479.
3. Chasnoff, I. J., Landress, H. & Barett, M. (1990) The prevalence of illicit drug and alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County. Florida. New England Journal of Medicine. 322, 1202-1206.
4. European Monitoring Center of Drugs and Drug Addiction (EMCDDA) (2000) Insights: Reviewing Current Practice in Drug-Substitution Treatment in the European Union. Luxembourg: Office for Official Publications of the European Communities.
5. Finnegan, L. P. (1991a) Perinatal substance abuse: Comments and perspectives. Seminars in Perinatology. 15, 331-339.
6. Finnegan, L. P. (1991b) Treatment issues for opioid-dependent women during the perinatal period. Journal of Psychoactive Drugs. 23, 191-201.
7. Finnegan, L. P. & Ehrlich, S. M. (1990) Maternal drug abuse during pregnancy: Evaluation for neonatal abstinence. In: Adler, M. & Cowan, A., eds. Modern Methods in Pharmacology, Vol. 6. Testing and Evaluation of Drugs of Abuse. pp. 225-263. New York: Wisley-Liss.
8. Finnegan, L.P. & Kaltenbach, K. (1992) Neonatal abstinence syndrome. In: Hoekelman, R. A., Friedmann, S. B., Nelson, N. & Millman, R. B., eds. Substance Abuse, a Comprehensive Textbook, 2nd Edn. pp. 628-656. Baltimore: Williams & Wilkins.
9. Fischer, G., Bitschau, M., Peternell, A., Eder, H. & Topitz, A. (1999b) Pregnancy and substance abuse. Archives of Women's Mental Health. 2, 57-65.
10. Fischer, G., Eder, H., Jagsch, R., Lennkh, C., Habeler, A., Aschauer, H. N. & Kasper, S. (1998) Maintenance therapy with synthetic opioids within a multidisciplinary program - A stabilizing necessity for pregnant opioid dependent women. Archives of Women's Mental Health. 1, 109-116.
11. Fischer, G., Gombas, W., Eder, H., Jagsch, R., Peternell, A., Stühlingen, G., Pezawas, L., Aschauer, H. N. & Kasper, S. (1999c) Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction, 94, 1337-1347.
12. Fischer, G., Jagsch, R., Eder, H., Gombas, W., Etzersdorfer, P., Schmidl-Mohl, K., Schatten, C. H., Weninger, M. & Aschauer, H. N. (1999a) Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction. 94, 231-239.
13. Fischer, G., Johnson, R. E., Eder, H., Jagsch, R., Peternell, A., Weninger, M., Langer, M. & Aschauer, H. N. (2000) Treatment of opioid-dependent pregnant women with buprenorphine. Addiction. 95, 239-244.
14. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerstrom, K. O. (1991) The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction. 86, 1119-1127.
15. Jarvis, M. A. & Schnoll, S. H. (1994) Methadone treatment during pregnancy. Journal of Psychoactive Drugs, 26, 155-161.
16. Jarvis, M. A., Wu-Pong, S., Knisley, J. S. & Schnell, S. H. (1999) Alterations in methadone metabolism during late pregnancy. Journal of Addiction Disorders. 18, 51-61.
17. Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A. & Bigelow, G. E. (1995) A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence. 40, 17-25.
18. Johnson, R. E., Jones, H. E., Jasinski, D. R., Svikis, D. S., Haug, N. A., Jansson, L. M., Kissin, W. B., Alpan, G., Lantz, M. E., Cone, E. J., Wilkins, D. G., Golden, A. S., Huggins, G. R. & Lester, B. M. (2001) Buprenorphine treatment of pregnant opioid-dependent women: Maternal and neonatal outcomes. Drug and Alcohol Dependence. 63, 97-103.
19. Kaltenbach, K. & Finnegan, L. P. (1986) Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehavioural Toxicology and Teratology. 8, 353-355.
20. Kandall, S. R. (1995) Treatment options for drug-exposed infants. In: Chiang, C. N. & Finnegan, L. P., eds. Medications Development for the Treatment of Pregnant Addicts and Their Infants. pp. 78-99. NIDA Research Monograph. vol. 149. Rockville. MD: Center for Substance Abuse Treatment.
21. Kandall, S. R., Doberczak, T. M., Jantunen, M. & Stein, J. (1999) The methadone-maintained pregnancy. Clinical Perinatology. 26, 173-183.
22. Kreek, M. J., Schecter, A., Gutjahr, C. L., Bowen, D., Field, F., Queenan, J. & Merkatz, I. (1974) Analyses of methadone and other drugs in maternal and neonatal body fluids: Use in evaluation of syndromes in an neonate of mother maintained in methadone. American Journal of Drug and Alcohol Abuse. 1, 409-419.
23. Levy, M. & Spino, M. (1993) Neonatal withdrawal syndrome: Associated drugs and pharmacological management. Pharmacotherapy. 13, 202-211.
24. Lewis, J. W., Rance, M. J. & Sanger, D. J. (1983) The pharmacology and abuse potential of buprenorphine: A new antagonistic analgesic. Advances in Substance Abuse. 3, 103-154.
25. Marquet, P., Chevrel, J., Lavignasse, P., Merle, L. & Lachatre, G. (1997) Buprenorphine withdrawal syndrome in a newborn. Clinical Pharmacology and Therapeutics. 62, 569-571.
26. McLellan, A., Kuschner, H., Metzger, D., Peters, R. M., Smith, I., Grisson, G., Pettinati, H. & Argeriou, M. (1992) Addiction Severity Index. 5th Edn. Journal of Substance Abuse Treatment. 9: 199-213.
27. Reisinger, M. (1985) Buprenorphine as new treatment for heroin dependence. Drug and Alcohol Dependence. 16, 257-262.
28. Strain, E. C., Stitzer, M. L., Liebson, I. A. & Bigelow, G. E. (1994) Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry. 151, 1025-1030.
29. Strain, E. C., Stitzer, M. L., Liebson, I. A. & Bigelow, G. E. (1996) Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology. 16, 58-67.
30. Syva Co. (1983) Emit® Assay Troubleshooting Guide
31. Theis, J. G., Selby, P., Ikizler, Y. & Koren, G. (1997) Current management of the neonatal abstinence syndrome: A critical analysis. Biology of the Neonate. 71, 345-356.
32. Treatment Improvement Protocol (TIP) Series (1993) Pregnant Substance-using Women. Rockville, MD: Center for Substance Abuse Treatment.
33. Virginia Apgar (1953) A proposal for a new method of evaluation of the newborn infant. Anesthesia and Analgesia. July-August, 261-262.
34. Walter, D. W. & Inturrisi, C. E. (1995) Absorption, distribution, metabolism and excretion of buprenorphine in animals and humans. In: Cowan, A. & Lewis, J. W., eds. Buprenorphine: Combatting Drug Abuse with a Unique Opioid. pp. 113-135. New York: Wiley-Liss.
35. Wang, E. C. (1999) Methadone treatment during pregnancy. Journal of Obstetric, Gynecologic and Neonatal Nursing. 28, 615-622.
36. Wojnar-Horton, R. E., Kristensen, J. H., Yapp, P., Ilett, K. F., Dusci, L. J. & Hacker, L. P. (1997) Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. British Journal of Clinical Pharmacology. 44, 543-547.